טוען...
Management of Patients with Inflammatory Diseases during the COVID-19 Pandemic
Patients with inflammatory diseases who receive moderate or high-risk anti-inflammatory therapies might be considered as an increased risk group for severe COVID-19 and appropriate measures should be taken in order to protect them. . Initiation of immuno-suppressive/modulatory therapies should be do...
שמור ב:
| הוצא לאור ב: | Mediterr J Rheumatol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Mediterranean Journal of Rheumatology (MJR)
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7656124/ https://ncbi.nlm.nih.gov/pubmed/33196008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.31.3.295 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|